Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|September 4, 2023
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentationBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2022
Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cellsRazie Amraei, Chaoshuang Xia, Judith Olejnik, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motifBlake M Hauser, Maya Sangesland, Evan C Lam, et al.
Cell Chemical Biology|April 23, 2016
GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E ProteinMargaret J Clark, Chandra Miduturu, Aaron G Schmidt, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Egyptian rousette bat humoral immunity to H9 influenza hemagglutininAnne A Roffler, Bruno Bonnettaz, Emerson Glassey, et al.
Science Immunology|November 14, 2025
CD21 primes extrafollicular differentiation of autoreactive B cells in a TLR7-driven lupus modelDanni Y Zhu, Daniel P Maurer, Carlos Castrillon, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamstersBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
Cell Reports|March 18, 2022
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprintingBlake M Hauser, Maya Sangesland, Kerri J St Denis, et al.
Science Immunology|October 14, 2021
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecovirusesJared Feldman, Julia Bals, Clara G Altomare, et al.
Pageof 11